Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

NRC stock hub

NRC Health has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NRCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

422.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NRC

In the news

Latest news · NRC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E48.7

P25 14.9P50 23.2P75 38.5

ROE41.9

P25 -105.6P50 -46.5P75 -3.1

ROIC18.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NRC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

253

Groups with data

Currency

USD

Showing 253 of 253 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000070487
Company name	NRC Health
Country	United States
Country code	US
Cusip	637372202
Employees	357
Employees Change	-11%
Employees Change Percent	-2.99
Enterprise value	$498M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Isin	US6373722023
Last refreshed	2026-05-10
Market cap	$422.6M
Market cap category	Small-Cap
Price	$18.75
Price currency	USD
Rev Per Employee	388,352.94x
Sector	Healthcare
Sic	8731
Symbol	NRC
Website	https://www.nrchealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.03%
EV Earnings	57.95x
EV/EBIT	18.9x
EV/EBITDA	14.39x
EV/FCF	28.57x
EV/Sales	3.59x
FCF yield	4.12%
P/B ratio	31.31x
P/E ratio	48.69x
P/S ratio	3.05x
PE Ratio10 Y	31.36x
PE Ratio3 Y	27.2x
PE Ratio5 Y	28.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.01%
EBITDA Margin	24.96%
FCF margin	12.57%
Gross margin	61.8%
Gross Profit	$85.7M
Gross Profit Growth	0.61%
Gross Profit Growth Q	3.24%
Gross Profit Growth3 Y	-2.71%
Gross Profit Growth5 Y	-0.14%
Net Income	$8.6M
Net Income Growth	-62.68%
Net Income Growth Q	-44.32%
Net Income Growth Years	0%
Net Income Growth3 Y	-33.89%
Net Income Growth5 Y	-24.12%
Pretax Margin	10.46%
Profit Margin	6.52%
Profit Per Employee	$24,073
Profitable Years	32
ROA	12.21
Roa5y	18.59
ROCE	27.42
ROE	41.86
Roe5y	50.94
ROIC	18.34
Roic5y	42.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.95%
Cagr1y	48.21%
Cagr3y	-21.24%
Cagr5y	-15.36%
Div CAGR10	-0.95%
Div CAGR3	0%
Div CAGR5	20.11%
EPS Growth	-62.25
EPS Growth Q	-44
EPS Growth Years	0
EPS Growth3 Y	-31.72
EPS Growth5 Y	-22.19
FCF Growth	16.68%
FCF Growth Q	46.07%
FCF Growth3 Y	-11.61%
FCF Growth5 Y	-17.24%
OCF Growth	-7.7%
OCF Growth Q	8.04%
OCF Growth10 Y	0.9%
OCF Growth3 Y	-8.93%
OCF Growth5 Y	-11.43%
Revenue Growth	-1.88x
Revenue Growth Q	3.73x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.5x
Revenue Growth5 Y	0.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.03
Assets	$134.6M
Cash	$2.5M
Current Assets	$20M
Current Liabilities	$38.5M
Debt	$78M
Debt EBITDA	$2.26
Debt Equity	$5.78
Debt FCF	$4.48
Equity	$13.5M
Interest Coverage	5.15
Liabilities	$121.1M
Long Term Assets	$114.6M
Long Term Liabilities	$82.6M
Net Cash	$-75.5M
Net Cash By Market Cap	$-17.86
Net Debt EBITDA	$2.18
Net Debt Equity	$5.59
Net Debt FCF	$4.33
Tangible Book Value	$-54.8M
Tangible Book Value Per Share	$-2.43
WACC	5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.52
Net Working Capital	$-17M
Quick ratio	0.36
Working Capital	$-18.5M
Working Capital Turnover	$-7.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.81%
Dividend Growth	25%
Dividend Growth Years	1%
Dividend per share	$0.64
Dividend Years	13
Dividend Yield	3.41%
Ex Div Date	2026-06-26
Last Dividend	$0.16
Payout Frequency	Quarterly
Payout Ratio	155.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	62.12%
1Y total return	48.17%
200-day SMA	15.92
3Y total return	-51.16%
50-day SMA	16.84
50-day SMA vs 200-day SMA	50over200
5Y total return	-56.55%
All Time High	71.35
All Time High Change	-73.72%
All Time High Date	2020-01-24
All Time Low	9.76
All Time Low Change	92.21%
All Time Low Date	2025-04-21
ATR	1
Beta	0.34
Beta1y	0.64
Beta2y	0.66
Ch YTD	-0.11
High	19.22
High52	22.79
High52 Date	2026-01-20
High52ch	-17.73%
Low	18.29
Low52	11.01
Low52 Date	2025-10-14
Low52ch	70.24%
Ma50ch	11.36%
Price vs 200-day SMA	17.8%
RSI	61.36
RSI Monthly	47.19
RSI Weekly	56.77
Sharpe ratio	0.92x
Sortino ratio	1.42
Total Return	9.23%
Tr YTD	0.81
Tr1m	10.04%
Tr1w	7.7%
Tr3m	18.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$26.4M
Operating Income Growth	-25.08
Operating Income Growth Q	-35.21
Operating Income Growth3 Y	-15.63
Operating Income Growth5 Y	-9.75
Operating margin	19.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,982,825%
Float Percent	53.17%
Net Borrowing	12,703,000
Shares Insiders	46.83%
Shares Institutions	50.67%
Shares Out	22,536,696
Shares Qo Q	0.48%
Shares Yo Y	-5.81%
Short Float	3.53%
Short Ratio	5.23
Short Shares	1.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$12.7M
Average Volume	98,232.55x
Bv Per Share	0.6
CAPEX	$-9.6M
Ch10y	31.58
Ch1m	10.04
Ch1w	7.7
Ch1y	43.24
Ch3m	17.63
Ch3y	-55.51
Ch5y	-61.67
Ch6m	27.55
Change	0.11%
Change From Open	-0.05
Close	18.73
Days Gap	0.16
Depreciation Amortization	8,251,000
Dollar Volume	2,414,212.5
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$26.4M
EBITDA	$34.6M
EPS	$0.39
F Score	5
FCF	$17.4M
FCF EV Yield	3.5x
FCF Per Share	$0.77
Financing CF	-17,385,000
Fiscal Year End	December
Founded	1,981
Goodwill	66,152,000
Graham Number	2.27777
Graham Upside	-87.85
Income Tax	$5.5M
Investing CF	-9,554,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Lynch Fair Value	$1.93
Lynch Upside	-89.73
Ma150	16.33
Ma150ch	14.85%
Ma20	17.57
Ma20ch	6.73%
Net CF	45,000
Next Earnings Date	2026-07-27
Open	18.76
Optionable	Yes
P FCF Ratio	24.24
P OCF Ratio	15.66
Payment Date	2026-07-10
Position In Range	49.46
Post Close	18.75
Postmarket Change Percent	0.05
Postmarket Price	$18.76
Ppne	40,305,000
Price Date	2026-05-08
Price EBITDA	$12.21
Relative Volume	1.31x
Revenue	138,642,000x
SBC By Revenue	3.43x
Share Based Comp	4,749,000
Tax By Revenue	3.94x
Tax Rate	37.69%
Tr6m	29.83%
Us State	Nebraska
Volume	128,758
Z Score	3.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NRC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.64 annual per share

Payout ratio

+155.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.1%

1 consecutive years of growth

Total shareholder yield

+9.2%

Next ex-dividend date: 2026-06-26

Performance

NRC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NRC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+50.7%

Float: +53.2% of shares outstanding

Insider ownership

+46.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NRC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.4

Neutral momentum band

Price vs 200-day MA

+17.8%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.92

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NRC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NRC stock rating?

NRC Health is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NRC analysis?

The full report lives at /stocks/NRC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NRC?

The latest report frames NRC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NRC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.